P. Wheelan et al., STEREOCHEMICAL ANALYSIS AND BIOLOGICAL-ACTIVITY OF 3-HYDROXY-LEUKOTRIENE B-4 - A METABOLITE FROM ETHANOL-TREATED RAT HEPATOCYTES, The Journal of pharmacology and experimental therapeutics, 271(3), 1994, pp. 1514-1519
Leukotriene B-4 (LTB(4)), a biologically active metabolite derived fro
m arachidonic acid by the 5-lipoxygenase cascade, is inactivated by cy
tochrome P-450-dependent omega-hydroxylation followed by second oxidat
ion into a omega-carboxyl group. In many tissues, this second step is
mediated by alcohol dehydrogenase. Isolated rat hepatocytes metabolize
d LTB(4) in the presence of ethanol and ethoxyresorufin into substanti
al quantities of 3-hydroxy-LTB(4) as determined by mass spectrometry.
The absolute configuration of this metabolite was found to be greater
than 98% 3(S)-hydroxy-LTB(4) by comparison to synthetic standards. Inv
estigation of the pharmacologic properties of the 3(S)- and 3(R)-hydro
xy-LTB(4) revealed that both caused a significant increase in intracel
lular free calcium in human neutrophils at 1 mu M. Both enantiomers al
so induced thromboxane A(2) release from the isolated guinea pig lung
in a dose-dependent manner. This activity was fully blocked by a speci
fic LTB(4) receptor antagonist, LY223982, with an IC50 of 0.21 mu M fo
r LTB(4). These results suggested that activation of the LTB(4) recept
or does not involve significant recognition of the carbon atoms close
to the carboxyl moiety of LTB(4). The failure of the hepatocyte to met
abolically inactivate LTB(4) in the presence of ethanol may be of impo
rtance to humans, particularly because the bioactive metabolite 3(S)-h
ydroxy-LTB(4) was further metabolized by human neutrophils significant
ly more slowly than LTB(4).